mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |